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Background: Free radical production is elevated in jugular venous blood emerging from the brain in conjunction 
with carotid endarterectomy. This study explores the relationships between markers for lesion progression in 
arteriosclerosis, production of radicals and clinical characteristics. 
Methods: The radical production during carotid endarterectomy was studied in 13 patients with an ex vivo spin 
trap method using OXANOH as a spin trap. MCP-1, ICAM-1, MMP-9 and oxLDL were determined in venous 
blood samples before, during and after clamping of the carotid artery. Principal component analysis (PCA) as 
well as partial least square regression analysis (PLS) was applied to interpret the data. 
Results: PCA and PLS analysis revealed that high values of MMP-9 and low values of ICAM-1 were associated 
with high radical production whereas MCP-1 and oxLDL were not correlated to radical production. MMP-9 was 
elevated at diabetes, high haemoglobin, high leucocyte counts and thrombocyte counts as well as at contralateral 
stenosis, whereas ICAM-1 showed reversed relationships to these clinical variables. MCP-1 increased during 
surgery.  
Conclusions: The main finding in our study is that MMP-9 in plasma is asscociated with radical production dur-
ing carotid endarterectomy, suggesting that this enzyme might be involved in the pathogenesis of brain damage 
in conjunction with ischaemia-reperfusion. 
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1.  INTRODUCTION 
In previous studies we have described a tech-
nique to analyze the production of free radicals during 
carotid endarterectomy based on determination of 
radical production in vitro in venous blood samples 
[1,2]. The rationale behind this in vitro technique is 
that radical production continues in regional venous 
blood draining a previously ischaemic area due to e.g. 
activated leucocytes or ongoing lipid peroxidation. 
Pre-treatment of the patients with a xanthine oxidase 
inhibitor influences radical production, indicating that 
oxidation of accumulated hypoxanthine has a role to 
play in this process. The radical production is influ-
enced by several clinical parameters, e.g. occurrence of 
contralateral stenosis, indicating that it is associated 
with the severity of the arteriosclerotic disease. There 
are several markers for the tissue damage characteris-
ing the lesion progression in arteriosclerosis, e.g. 
MMP-9, ICAM-1, MCP-1 and oxLDL.   
Rupture of atherosclerotic plaques is a key proc-
ess in symptomatic atherosclerosis. Fibrous caps from 
ruptured atherosclerotic plaques contain less ex-
tracellular matrix than caps from intact plaques [3]. 
Enhanced matrix breakdown seems to be largely at-
tributable to matrix-degrading metalloproteinases 
(MMP), which are expressed in atherosclerotic 
plaques, mainly by macrophages and foam cells [3]. 
The MMP family is catalytically active, both in vitro 
and in vivo. The activity of MMPs is increased by gene 
transcription, extracellular activation of the secreted 
inactive zymogen form, and reduced activity of tissue 
inhibitors of metalloproteinases. Latent MMPs can be 
activated by a number of molecules existing in the 
atherosclerotic plaque, of which several are produced 
b y  t h e  m a c r o p h a g e s ,  e . g .  p l a s m i n ,  r e a c t i v e  o x y g e n  
species and others [3]. Serum concentration of MMP-9 
has been suggested as a biomarker of plaque vulner-
ability [4]. In diabetic patients, carotid artery plaques 
have more macrophages and higher levels of MMP-9 
than non-diabetic patients [5].   
The intercellular adhesion molecule ICAM-I me-
diates adhesion and transmigration of leucocytes to 
the vascular endothelial wall, a step suggested as be-
ing critical in the initiation and progression of athero-
sclerosis. Circulating ICAM-I is associated with a fu-Int. J. Med. Sci. 2007, 4 
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ture risk of stroke [6] and is elevated in diabetic pa-
tients [7].   
Monocyte chemoattractant protein-1 (MCP-I) 
originates from endothelial, epithelial, and glial cells 
and mediates recruitment of monocytes into tissues 
[8,9].  
Oxidised LDL (oxLDL) seems to be a key antigen 
in atherosclerosis and circulating levels of oxLDL have 
been observed to predict the development of carotid 
artery atherosclerosis [10,11].   
Apart from atherosclerotic lesions, cerebral is-
chaemic damage may also cause increased radical 
production and expression of ICAM-1 and MCP-1, or 
be associated with increased MMP-9 production 
[12-16].  
Accordingly, we explored whether there were 
any associations between the levels of MMP-9, MCP-1, 
ICAM-1, oxLDL, and free radicals in blood from the 
jugular vein, as well as variables related to athero-
sclerosis during endarterectomy. 
 
2.  MATERIAL AND METHODS 
2.1. Patients 
The 13 patients included in the present study 
were identical to the control group in our previous 
work concerning the effects of pre-treatment with a 
xanthine oxidase inhibitor on free radical levels dur-
ing carotid endarterectomy in patients operated on for 
symptomatic carotid artery stenosis [2]. Relevant data 
concerning the patients are presented in Table 1. 





The patients were premedicated with a combina-
tion of pethidine and dixyrazine (Esucos®) according 
to their weight and were then operated on under fen-
tanyl-assisted general anaesthesia. 
2.2.2. Operation 
The operation performed was described in detail 
in our previous article. Briefly, the carotid artery was 
exposed via an incision along the anterior border of 
the sternocleidomastoid muscle. A 1-mm catheter was 
inserted via the facial vein into the jugular vein and 
advanced up to the level above the skull base, and the 
facial vein was divided. The catheter was advanced 
12-15 cm up until resistance and then withdrawn 1 cm 
until blood could be aspired without resistance. The 
common carotid and internal carotid artery were iso-
lated separately without touching the carotid bifurca-
tion, whereafter the external carotid artery was iso-
lated.  
After clamping the common and external carotid 
artery, stump pressure was measured using an arterial 
pressure monitor via a needle inserted into the inter-
nal carotid artery distal to the stenotic lesion. A shunt 
was not considered necessary in any case. After 
clamping the internal carotid artery, the internal and 
common carotid arteries were opened via a longitu-
dinal arteriotomy and the plaque removed. 
The arteriotomy was closed using 6-0 prolene 
continuous sutures. In two cases, in each group, the 
arteriotomy was closed using a patch to avoid nar-
rowing of the internal carotid artery. There was no 
mortality and no cardiac or cerebral complications.   
2.2.3. Sampling procedure 
After declamping, blood flow was monitored 
using a sterile doppler probe and a flow meter 
(Medistim R, Vingmed, Sweden). From the catheter, 
inserted into the jugular vein, 4 cm3 blood samples 
were drawn three times at 5-minute intervals, before 
clamping the carotid artery, once one minute after 
clamping and once three minutes before declamping. 
Another four 4-cm3 samples were drawn at 1, 5, 10 
and 15 minutes after declamping. Due to the place-
ment of the catheter it is unlikely that the blood sam-
ples were contaminated with blood from the external 
head.  
After heparinisation, each venous blood sample 
was divided into two 1-ml portions (one sample and 
one blank) and pipetted into Eppendorf tubes. 
OXANOH (v.i.) (1 mM final concentration) was added 
to both tubes. In order to distinguish the part of the 
electronic spin resonance (ESR) signal attributable to 
superoxide and/or hydroxyl radicals, superoxide 
dismutase, catalase and desferrioxamine were added 
to the blank tube to a final concentration of 0.1 mg ml-1, 
16,000 units ml-1 and 0.4 mg ml-1, respectively. The 
same volume of isotonic sodium chloride as used to 
solute the scavenger substances was added to the 
sample tube. Subtraction of the ESR signal seen in the 
samples treated with an antioxidant cocktail from that 
of the saline samples yields the part of the signal that 
can be attributed to superoxide and/or hydroxyl 
radicals or any secondary radicals dependent on these. 
The tubes were shaken and centrifuged at 14,000 rpm 
for one minute. The plasma was removed immediately 
and frozen in liquid nitrogen and the time from sam-
pling to freezing was thus less than two minutes.   Int. J. Med. Sci. 2007, 4 
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2.2.4. Measurement of radical production 
OXANOH was used as a spin trap. The stable ni-
troxide radical 2-ethyl-2,4,4-trimethyloxazolidine-
-3-3-yloxy (OXANO•) was reduced to the hydroxyl-
amine spin trap 2-ethyl-3-hydroxy-2,4,4--
trimethyloxazolidine (OXANOH) by gassing a 10 mM 
solution of the radical with hydrogen for 45 minutes 
in the presence of the catalyst platinum dioxide (PtO2). 
On contact with a radical, OXANOH is reoxidised to 
OXANO•, which can be measured by ESR. The spin 
trap was freshly prepared before each experiment and 
kept on ice until used.   
The samples were transported to the electronic 
spin resonance laboratory and thawed. The concentra-
tion of OXANO• was analysed using a Bruker ECS 106 
ESR spectrometer. The spectrometer settings were as 
follows: field centre, 3478 G; modulation amplitude, 1 
G; microwave power, 10 mW; microwave frequency, 
9.70 GHz; scan range, 5 G; scan rate, 1 G s-1; time con-
stant, 20 ms. The ESR signal was quantified by signal 
height peak to trough. 
The concentration of OXANO in the blank sam-
ple was subtracted from that of the corresponding test 
sample. Around ten per cent of the signal was dimin-
ished as a result of the inhibitors. 
 
2.2.5. Measurement of MCP-1, ICAM-1, MMP-9 and oxLDL 
Blood samples were withdrawn for an analysis of 
markers of arteriosclerosis together with OXANO 
samples 1, 5 and 9, i.e. before clamping, just before 
declamping and 15 minutes after start of reperfusion. 
The blood samples were heparinised and centrifuged, 
whereafter the plasma was frozen in liquid nitrogen 
for later analysis. MCP-1, ICAM-1 and MMP-9 were 
measured using commercially available ELISA kits 
from R&D systems, UK.   
OxLDL concentration in plasma that had been 
stored at –70ºC was measured by a sandwich ELISA 
(Mercodia, Uppsala, Sweden) utilizing the same spe-
cific murine monoclonal antibody, mAb-4E6, as in the 
assay described by Holvoet et al [17]. Using this anti-
body (mAb-4E6) it is possible to measure very small 
amounts OxLDL containing a conformational epitope 
in the apoB-100 moiety of LDL that is generated as a 
consequence of substitution of lysine residues of 
apoB-100 with malondialdehyde. The specificity for 
the antibody mAb-4E6 has been assessed, showing 
that 50% inhibition of binding of mAb-4E6 to immobi-
lized OxLDL was obtained with 0.025 mg/dl Cu2+ 
OxLDL and with 25 mg/dl native LDL [18]. In the 
presently used sandwich ELISA, the plates are coated 
with the capture antibody (mAb-4E6), and the secon-
dary antibody specifically detects apoB. In a set of 20 
EDTA-plasma samples collected from 20 different in-
dividual blood-donors no unspecific binding of native 
LDL to the solid phase in the Mercodia oxidized LDL 
ELISA system was detected (data not shown). The 
precision has in our hands previously been shown to 
be satisfactory [19]. 
2.3. Statistics 
The mean values for concentrations of OXANO 
and markers of arteriosclerosis before, during and af-
ter clamping are given. When analysing the relations 
between radical production and concentrations of 
MCP-1, ICAM-1, MMP-9 and oxLDL, mean values for 
all the OXANO concentrations measured during 
clamping and reperfusion and for the markers sam-
pled before, during and after clamping were used. In 
the PLS models, where values for MMP-9 and ICAM-1 
were compared to various parameters, mean values 
for the markers obtained before, during and after 
clamping were used. 
Due to the small number of patients, standard 
descriptive statistics did not seem optimal. Instead, 
principal component analysis (PCA) was performed 
on the total data set. All variables were scaled to zero 
mean and unit variance. A detailed description of the 
computational steps involved in a PCA is given in Ref. 
20. In essence, a variance/covariance matrix is calcu-
lated based on the scaled variables. Principal compo-
nents are calculated as the eigen-vectors of this matrix, 
yielding the variable loadings shown in variable 
loading plots. The first principal component has the 
capacity to encompass a maximum of the variance in 
one single vector, which is a linear combination of all 
variables analysed. Each subsequent component con-
stitutes an independent linear combination of vari-
ables, capturing a maximum of the variance remaining 
in the data set, and is orthogonal to all other compo-
nents. In biological material, with a considerable de-
gree of collinearity between the variables measured, 
the first component thus represents a large part of all 
information, compressed into one variable. The sub-
sequent principal components represent independent 
information, in decreasing order of magnitude. In ad-
dition to reducing a large data set to a few compo-
nents that can be easily overviewed, principal com-
ponent-based analyses have important, inherent 
noise-reducing properties due to the simultaneous 
analysis of several variables. This is analogous to the 
reduction in noise gained by using large samples, 
where the large number of objects increases the preci-
sion of, for example, the sample mean. Results thus 
generated by PCA-based methods are more robust 
than corresponding univariate descriptors or bivariate 
correlation analyses. Compared with multiple regres-
sion techniques, the latter are highly sensitive to dis-
tribution and colinearities, while PCA can be applied 
to any kind of data, regardless of distribution, and, as 
outlined above, utilises the covariances to reduce 
noise and to compact the data. In subsequent analyses, 
Partial Least Square (PLS) regression analyses were 
applied [20]. As with PCA, the principal components 
are extracted with the modification that they are con-
strued to find a regression between X- and Y-data in 
addition to producing a compact representation of the 
data. In the calculation of principal components, the 
components of the X-block that produce the strongest 
linear relation to the Y-variables are extracted. The 
principal difference is that in PLS, a number of (one or Int. J. Med. Sci. 2007, 4 
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several) Y-variables are defined. For the regression 
coefficients yielded in PLS analyses, standard errors 
were estimated using the jack-knife procedure [21], 
which is a non-parametric, general principle for the 
estimation of errors in various estimates, suitable for 
PLS regression coefficients. All PCA and PLS models, 
as well as graphics and standard error estimates, were 
generated using the Simca-P 8.0 Software (Umetrics, 
Inc.). 
A n o v a  a n d  p a i r e d  T - t e s t  w e r e  u s e d  t o  t e s t  f o r  
differences in concentrations of MCP-1, ICAM-1, 
MMP-9 and oxLDL with time during the operations 
and p < 0.05 (two-sided) was considered statistically 
significant. 
3.  RESULTS 
The mean values for all OXANO measurements 
performed during and after clamping were numeri-
cally higher than the baseline measurements although 
no statistically significant change was observed due to 
the great variations (Fig. 1).   
 
Fig. 1  Free radical production measured in vitro in blood sam-
ples from the internal jugular vein. Mean values + SEM are 
given for OXANO values obtained before clamp, during clamp 
and at reperfusion. n = 13. 
The atherosclerosis markers show some changes 
during surgery (Fig. 2). MCP-1 increased significantly 
from the first time-point to the second and third ones, 
while oxLDL tended to decrease. No statistically sig-
nificant change was observed concerning MMP-9 and 
ICAM-1. 
The outcome of the PCA of the radical data, data 
concerning the degree of arteriosclerotic disease and 
some relevant clinical data are shown in Figure 3. In 
order to increase the lucidity of the figure the PCA has 
been modified by presenting the OXANO values as 
mean values before, during and after clamping the 
carotid artery. The OXANO radical levels (PL, I, RP) 
are located in a cluster at the far left of the X-axis to-
gether with the MMP-9 values, indicating a positive 
correlation between these variables. ICAM-1 values 
are located in the opposite direction, indicating a 
negative correlation with OXANO levels as well as 
MMP values. MCP-1 and oxLDL values are close to 
origin, indicating a lack of correlation between these 
values and any of the other variables. 
MMP-9 values appear from this PCA to be posi-
tively correlated to e.g. platelets, leucocytes and dia-
betes and negatively correlated to age, while the op-
posite situation appears to be true for ICAM-1 values. 
A closer analysis of the significances of these re-
lationships is given in the PLS analyses. The PLS re-
gression analysis describing how OXANO levels de-
pend on values for oxLDL, MMP-9, ICAM-1 and 
MCP-1 is presented in Figure 3. As suggested from the 
PCA analysis, there is a strong positive correlation 
between MMP-9 and radical production and a nega-
tive correlation between ICAM-1 values and OXANO 
levels.  
The regression coefficients relating various clini-
cal parameters and MMP-9 or ICAM-1 values are 
shown in Figures 4 and 5 respectively.   
 
Fig. 2   Mean values (SEM) of oxLDL, MMP9, ICAM1 and 
MCP1 determined before clamping (1), during clamping (5) and 
15 minutes after declamping (9). Stars denote significant dif-
ferences compared to preclamp values. * p < 0.05, ** p < 0.01. 
 
Fig. 3  Variable loadings derived from a PCA of some of the 
recorded data. The position of each variable in the loading plot 
indicates its relationship to other variables. Strongly correlated 
variables are located close to each other. Abbreviations: PL, I 
and RP OXANO levels at baseline, clamp and reperfusion re-
spectively. MCP11, MCP15, MCP19; MCP levels before, dur-
ing and after clamping, ICAM11, ICAM15, ICAM19; ICAM 
levels before, during and after clamping, MMP91, MMP95, 
MMP99; MMP9 levels before, during and after clamping, 
oxLDL1, oxLDL5, oxLDL9; oxLDL levels before, during and 
after clamping, Collateral; degree of collateral circulation, 
Stenosis; degree of ipsilateral stenosis, Left; operation for Int. J. Med. Sci. 2007, 4 
 
128
left-side stenosis, Diabetes; occurrence of diabetes, Leucocyt; 
white blood cell count, Hb; haemoglobulin concentration, 
Trombocyt; trombocyte count. 
 
Fig. 4 Regression coefficients in a PLS model relating radical 
production to oxLDL, MMP9, ICAM1 and MCP1 determined 
before clamping (1), during clamping (5) and 15 minutes after 
declamping (9). Shown are scaled and centred regression coef-
ficients with standard errors estimated by the jack-knife pro-
cedure. If the bars do not include the zero line a significant 
relationship prevails. A positive coefficient indicates a positive 
relationship to radical production and vice versa.  
 
 
Fig. 5   Regression coefficients in a PLS model relating MMP9 
levels to various clinical variables. Shown are scaled and cen-
tred regression coefficients with standard errors estimated by the 
jack-knife procedure. If the bars do not include the zero line a 
significant relationship prevails. A positive coefficient indicates 
a positive relationship to radical production and vice versa.  
  
Fig. 6   Regression coefficients in a PLS model relating ICAM1 
levels to various clinical variables. Shown are scaled and cen-
tred regression coefficients with standard errors estimated by the 
jack-knife procedure. If the bars do not include the zero line a 
significant relationship prevails. A positive coefficient indicates 
a positive relationship to radical production and vice versa.  
Increased MMP-9 values are found in conjunc-
tion with diabetes, high haemoglobin, leucocyte and 
platelet values and at contralateral stenosis while low 
values are found in conjunction with high age, high 
blood pressure, operation for left-side stenosis and 
high stump pressure. 
As regards ICAM-1, high values are found in 
conjunction with heavy weight, operation for left-side 
stenosis and high stump pressure. Low values are 
found in conjunction with diabetes, high haemoglobin, 
leucocyte and thrombocyte values and when a contra-
lateral stenosis is present. 
4.  DISCUSSION 
The present study concerns the relationships 
between the production of free radicals during and 
after operation for stenosis of the carotid artery and 
blood levels of ICAM-1, MMP-9, MCP-1 and oxLDL. 
Radical production has been calculated using an ex 
vivo spin trap technique with OXANOH as the spin 
trap. High values for MMP-9 and low values for 
ICAM-1 were associated with high levels of free radi-
cals. Several correlations were found between the 
values of MMP-9 and ICAM-1 and different clinical 
variables. In an earlier study where the present group 
of patients were included as controls and compared to 
allopurinol-pretreated patients, relations between 
various clinical variables and radical production were 
reported [2]. 
MMPs are a group of zinc-dependent enzymes 
that degrade the molecules of the extracellular matrix. 
It has been shown that matrix degradation caused by 
these proteinases occurs during progression of 
atherosclerosis [22]. Furthermore, an increase in MMP 
activity occurs after stroke, which contributes to is-
chaemic brain injury, including infiltration of leuco-
cytes in the damaged tissue [12-14]. In animal experi-
ments it has been demonstrated that inhibition of 
MMP-9 reduces brain injury after stroke [23]. MMP-9 
levels are increased in internal jugular venous blood 
after traumatic brain injury in patients [15]. These 
studies indicate that MMP-9 is involved in the patho-
genesis of brain damage due to various causes. Our 
results of a positive correlation between levels of free 
radicals and MMP-9 at operation for carotid artery 
stenosis further support this role of metalloproteinases 
in brain tissue damage. The positive correlation be-
tween MMP-9 and leucocyte counts also appears 
logical since neutrophils can also produce these en-
zymes [14]. Our finding of a positive association be-
tween MMP-9 and diabetes fits in well with previous 
observations [5].  
The occurrence of contralateral stenosis was as-
sociated with higher MMP-9 values, suggesting that a 
more severe atherosclerotic disease causes elevated 
MMP-9 levels. Inhibition of MMP-9 in conjunction 
with these operations might be useful to decrease pos-
sible brain damage.   
The plasma concentration of ICAM-1 as well as 
other adhesion molecules is increased in conjunction 
with transient ischaemic attacks, indicating a central Int. J. Med. Sci. 2007, 4 
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nervous system inflammatory reaction [16].  In the 
present study we found no correlation between 
MCP-1 and radical levels and a negative correlation 
between ICAM-1 and these levels. The lack of a posi-
tive correlation between radicals and these markers of 
inflammation, as well as between clinical parameters 
known to be associated with increased radical produc-
tion, indicates that the possible hypoperfusion that 
occurs during carotid endarterectomy, and which is 
responsible for radical production, is not enhanced 
enough to cause cerebral inflammation, resulting in 
increased ICAM-1 and MCP-1 values. There was a 
significant increase in the concentration of MCP-1 
during and after carotid endarterectomy compared 
with before clamping of the artery. Taken together, 
these findings indicate that the concentration of 
MCP-1 increases during surgery via a mechanism 
other than radical production.   
One possible explanation for the lack of a posi-
tive correlation between ICAM-1 and radical produc-
tion in the present series is that our patients suffered 
from late-stage atherosclerosis. In previous studies it 
has been shown that plasma levels of ICAM-1 are as-
sociated with sub-clinical femoral atherosclerosis in 
clinically healthy middle-aged men; and also with 
endothelial function in healthy young subjects [24,25]. 
Various stages of atherosclerosis in different patient 
populations might explain why various authors report 
different results regarding ICAM-1 and the risk of 
cerebrovascular complications. Elevated concentra-
tions of ICAM-1 were reported to be associated with 
an increased risk of stroke [6] whereas no correlation 
was found between the expression of ICAM-1 and the 
severity of symptomatic carotid disease [26].  
Oxidised, low-density lipoprotein (oxLDL) is 
found within the atherosclerotic blood vessels but not 
normal blood vessels [27]. OxLDL has an important 
role to play in atherogenesis since it attracts mono-
cytes into the vascular intima and transforms them 
into foam cells [28]. Since blood is rich in a variety of 
antioxidants “fully oxidised LDL” does not exist in the 
circulation [28]. Nevertheless, small amounts of 
oxLDL are found in the circulation and a correlation 
between oxLDL and plaque occurrence in the carotid 
and femoral arteries has been demonstrated [11,19]. In 
the present study we did not find any association be-
tween radical production and oxLDL in plasma. 
However, it should be kept in mind that we only ex-
amined one of many epitopes that may be oxidized in 
LDL.  
The limitation of the present study is that it in-
cluded only patients with unstable carotid atheroscle-
rotic plaques leading to symptomatic ischaemic dis-
ease, and that we had no reliable measure of the de-
gree o f d am age t o  b r ain  t issu e. H en c e , w e c an  o n l y 
interpret the associations between the markers studied 
and the free radical levels and factors related to 
atherosclerotic disease. Furthermore, it must be em-
phasised that the study is based on a limited number 
of patients, and the measurements are subject to a 
substantial variability. Thus, the study should be re-
garded as hypothesis-generating rather than conclu-
sive, with respect to the relationships observed be-
tween the variables collected.   
We conclude that the major finding in the present 
study was that MMP-9 in plasma was related to the 
production of free radicals during carotid endarterec-
tomy and also other variables known to co-variate 
with MMP-9, such as leucocyte count, diabetes and 
more extensive atherosclerosis. Furthermore, MCP-1 
increased during surgery and this was not associated 
with radical formation.   
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